Dietary vitamin A and teratogenic risk: European Teratology Society discussion paper

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 83, Issue 1, 1999, Pages 31-36

  Dolk, Helen M ^a   Nau, Heinz ^b   Hummler, Hans ^c   Barlow, Susan M ^d  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

^c Untere Burghalde 14   (Switzerland)

^d 8 Harrington Road ^*  (United Kingdom)

Author keywords

Animal studies; Epidemiology; Public health advice; Teratogenicity; Vitamin A

Indexed keywords

RETINOL;

ANIMAL MODEL; CONGENITAL MALFORMATION; DIET; HUMAN; NONHUMAN; ORAL DRUG ADMINISTRATION; PREGNANCY; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK ASSESSMENT; TERATOGENICITY;

EID: 0033034932     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-2115(98)00228-0     Document Type: Article

References (52)

1. Health Council/Food and Nutrition Council. Vitamin A and Teratogenicity. The Hague, The Netherlands, 1994.
2. European Commission. Reports of the Scientific Committee for Food, Thirty-first Series: Nutrient and energy intakes for the European Community. EC Directorate-General Industry, Luxembourg, 1993.
3. Parker R.S. Absorption, metabolism, and transport of carotenoids. FASEB J. 10:1996;542-551.
4. Werler M.W., Lammer E.J., Rosenberg L., Mitchell A.A. Maternal vitamin A supplementation in relation to selected birth defects. Teratology. 42:1990;497-503.
5. Rothman K.J., Moore L.L., Singer M.R., Nguyen U.D.T., Mannino S., Milunsky A. Teratogenicity of high vitamin A intake. New Engl J Med. 333:1995;1369-1373.
6. Hurley LS. Nutritional deficiencies and excesses. In: Wilson JG, Fraser FC, editors. Handbook of Teratology. 1. General Principles and Etiology. New York & London: Plenum Press, 1977:269-270.
7. Department of Health. Dietary reference values for food energy and nutrients for the United Kingdom: Report of the panel on dietary reference values of the Committee on Medical Aspects of Food Policy. London: HMSO, 1991.
8. National Research Council. Recommended Dietary Allowances, 10th ed. Washington DC: National Academy Press, 1989.
9. Bauernfield JC. The safe use of vitamin A: a report of the International Vitamin A Consultative Group (IVACG), 1980.
10. Food and Nutrition Council. Recommended dietary allowances. Food and Nutrition Council: The Hague, The Netherlands, 1992.
11. Nicol M. Vitamin A. In: Apports nutritionnels conseillés pour la population francaise. Coll Tec Doc. Paris: 5255, 1992.
12. Deutsche Gesellschaft für Ernährung. Empfehlungen für die Nährstoffzufuhr. Frankfurt: Umschau, 1991.
13. Anonymous. Vitamin A supplementation during pregnancy. ACOG opinion: Committee on Obstetrics: Maternal and Fetal Medicine: Number 112, August 1992. Int J Gynecol Obstet 1993;40:175.
14. Nau H, Chahoud I, Dencker L, Lammer EJ, Scott WJ. Teratogencity of vitamin A and retinoids. In: Blomhoff R, editor. Vitamin A in Health and Disease. New York: Marcel Dekker, 1994:615-663.
15. Teratology Society. Teratology Society Position Paper. Recommendations for vitamin A use during pregnancy. Teratology. 35:1987;269-275.
16. Rosa F.W., Wilk A.L., Kelsey F.O. Teratogen update: Vitamin A congeners. Teratology. 33:1986;355-364.
17. Hendrickx A.G., Hummler H., Oneda S. Vitamin A teratogenicity and risk assessment in the cynomolgus monkey. Teratology (Abstract). 55:1997;68.
18. Hummler H., Korte R., Hendrickx A. Induction of malformations in the cynomolgus monkey with 13-cis-retinoic acid. Teratology. 42:1990;263-272.
19. Folman Y., Russell R.M., Tang G.-W., Wolf G. Rabbits fed on β-carotene have higher serum levels of all-trans retinoic acid than those receiving no β-carotene. Br J Nutr. 62:1989;195-201.
20. Napoli J.L., Race K.R. Biogenesis of retinoic acid from β-carotene. Differences between the metabolism of β-carotene and retinal. J Biol Chem. 263:1988;17372-17377.
21. Wang X.-D., Tang G.-W., Fox J.G., Krinsky N.I., Russell R.M. Enzymatic conversion of β-carotene to β-apo-carotenals and retinoids by human, monkey, ferret and rat tissues. Arch Biochem Biophys. 285:1991;8-16.
22. Hebuterne X., Wang X.-D., Smith D.E.H., Tang G., Russell R.M. In vivo biosynthesis of retinoic acid from β-carotene involves an excentric cleavage pathway in ferret intestine. J Lipid Res. 37:1996;482-492.
23. Brown E., Micozzi M.S., Craft N.E., Bieri J.G., Beecher G., Edwards B.K., Rose A., Taylor P.R., Smith J.C.J. Plasma carotenoids in normal men after a single ingestion of vegetables or purified β-carotene. Am J Clin Nutr. 49:1989;1258-1265.
24. Heinonen O.P., Albanes D. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. The effect of vitamin E and beta-carotene on the incidence of lung cancer and other cancers in male smokers. New Engl J Med. 330:1994;1029-1035.
25. Dimitrov N.V., Meyer C., Ullrey D.E., Chenoweth W., Michelakis A., Malone W., Boone C., Fink G. Bioavailability of β-carotene. Am J Clin Nutr. 48:1988;298-304.
26. de Pee S., West C.E., Muhllal, Karyadi D., Hautvast G.A.J. Lack of improvement in vitamin A status with increased consumption of dark-green leafy vegetables. Lancet. 346:1995;75-81.
27. Buss N.E., Tembe E.A., Prendergast B.D., Renwick A.G., George C.F. The teratogenic metabolites of vitamin A in women following supplements and liver. Hum Exp Toxicol. 13:1994;33-43.
28. Eckhoff C.h., Nau H. Vitamin A supplementation increases levels of retinoic acid compounds in human plasma: possible implications for teratogenesis. Arch Toxicol. 64:1990;512-513.
29. Eckhoff C., Collins M.D., Nau H. Human plasma all-trans, 13-cis- and 13-cis-4-oxo-retinoic acid profiles during subchronic vitamin A supplementation: comparison to retinol and retinyl ester plasma levels. J Nutr. 121:1991;1016-1025.
30. Chen C., Mistry G., Jensen B., Heizmann P., Timm U., van Brummelen P., Rakhit A.K. Pharmacokinetics of retinoids in women after meal consumption or vitamin A supplementation. J Clin Pharmacol. 36:1996;799-808.
31. Arnhold T., Tzimas G., Wittfoht W., Plonait S., Nau H. Identification of 9-cis-retinoic acid, 9,13-di-cis-retinoic acid, and 14-hydroxy-4,14-retro-retinol in human plasma after liver consumption. Life Sci. 59 PL:1996;169-177.
32. Eckhoff C., Löfberg B., Chahoud I., Bochert G., Nau H. Trans-placental pharmacokinetics and teratogenicity of a single dose of retinol (vitamin A) during organogenesis in the mouse. Toxicol Lett. 48:1989;171-184.
33. Collins M.D., Tzimas G., Hummler H., Bürgin H., Nau H. Comparative teratology and transplacental pharmacokinetics of all-trans retinoic acid, 13-cis retinoic acid, and retinyl palmitate following daily administrations in rats. Toxicol Appl Pharmacol. 127:1994;132-144.
34. Tzimas G., Collins M.D., Nau H. Identification of 14-hydroxy-4,14-retro-retinol as an in vivo metabolite of vitamin A. Biochim Biophys Acta. 1301:1996;1-6.
35. Tzimas G., Collins M., Bürgin H., Hummler H., Nau H. Embryotoxic doses of vitamin A to rabbits result in low plasma but high embryonic concentrations of all-trans-retinoic acid: risk of vitamin A exposure in humans. J Nutr. 126:1996;2159-2171.
36. Lammer E.L., Chen D.T., Hoar R.M., Agnish N.D., Benke P.J., Braun J.T., Curry C.J., Ferhoff P.M., Grix A.W., Lott I.T., Richard J.M., Sun SC Retinoic acid embryopathy. New Engl J Med. 313:1985;837-841.
37. Hendrickx A.G., Hummler H. Teratogenicity of all-trans retinoic acid during early embryonic development in the cynomolgus monkey (Macaca fascicularis). Teratology. 45:1992;65-74.
38. Korte R., Hummler H., Hendrickx A.G. Importance of early exposure to 13-cis retinoic acid to induce teratogenicity in the cynomolgus monkey. Teratology. 47:1993;37-45.
39. Hummler H., Hendrickx A.G., Nau H. Maternal toxicokinetics, metabolism, and embryo exposure following a teratogenic dosing regimen with 13-cis-retinoic acid (isotretinoin) in the cynomolgus monkey. Teratology. 50:1994;184-193.
40. Soprano D.R., Soprano K.J. Retinoids as teratogens. Ann Rev Nutr. 15:1995;111-132.
41. Kochhar D.M., Jiang H., Penner J.D., Heyman R.A. Placental transfer and developmental effects of 9-cis-retinoic acid in mice. Teratology. 51:1995;257-265.
42. Rosa FW. Retinoid embryopathy in humans. In: Koren G, editor. Retinoids in Clinical Practice. The Risk-Benefit Ratio. New York: Marcel Dekker, 1993:77-109.
43. Martinez-Frias M.L., Salvador J. Epidemiological aspects of prenatal exposure to high doses of vitamin A in Spain. Eur J Epidemiol. 6:1990;118-123.
44. Rothman K.H., Moore L.L., Singer M.R., Milunsky A. New Engl J Med (Letter). 334:1996;1197.
45. Werler M.W., Lammer E.J., Mitchell A.A. New Engl J Med (Letter). 334:1996;1195.
46. Brent R.L., Hendrickx A.G., Holmes L.B., Miller R.K. New Eng J Med (Letter). 334:1996;1196.
47. Shaw G.M., Wasserman C.R., Block G., Lammer E.J. High maternal vitamin A intake and risk of anomalies of structures with a cranial neural crest cell contribution. Lancet. 347:1996;899-900.
48. Dudas I., Czeizel A.E. Use of 6000 IU vitamin A during early pregnancy without teratogenic effects. Teratology. 45:1992;335-336.
49. Oakley G.P., Erikson J.D. Vitamin A and birth defects. Continuing caution is needed. New Engl J Med. 333:1996;1414-1415.
50. Khoury M.J., Moore C.A., Mulinare J. Vitamin A and birth defects. Lancet. 347:1996;321-322.
51. Department of Health and Ministry of Agriculture, Fisheries and Food. Vitamin A Information Pack. London, UK, 1990.
52. Nordic Working Group on Food Toxicology and Risk Evaluation. Consensus document on health risks associated with high intake of vitamin A, 1990-11-23, 1990.